Jun 21, 2021 / 07:20PM GMT
Dane Leone - Raymond James Financial, Inc. - Analyst
Greetings, everyone. Welcome to the next session here at the Raymond James 2021 Human Health Innovation Conference. My name is Dane. I'm one of the senior biotech analysts at Raymond James. With this session, I'm excited to have the Nkarta team with us. We're going to have a fireside chat and get into their NK cell platform, discuss some of the programs that they have, and hopefully answer any questions that you may have as we go along on this discussion.
To start off, I think we will have maybe, Paul, the CEO, give a grief background, introduce the team, and then we will get into some Q&A. Paul, welcome. Thank you so much for joining us.
Paul Hastings - Nkarta, Inc. - Chief Executive Officer
Dane, thank you for having us. And the beauty of Zoom is that you have the entire management team here with us today. So rather than introduce everybody, I will let you know that James Trager, our CSO, is on; Kanya Rajangam, our Chief Medical Officer, is on; Nadir Mahmood, our Chief Financial and Business
Nkarta Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 22, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers